• 中国精品科技期刊
  • 《中文核心期刊要目总览》收录期刊
  • RCCSE 中国核心期刊(5/114,A+)
  • Scopus收录期刊
  • 美国《化学文摘》(CA)收录期刊
  • WHO 西太平洋地区医学索引(WPRIM)收录期刊
  • 《中国科学引文数据库(CSCD)》核心库期刊 (C)
  • 中国科技核心期刊
  • 中国科技论文统计源期刊
  • 《日本科学技术振兴机构数据库(中国)》(JSTChina)收录期刊
  • 美国《乌利希期刊指南》(UIrichsweb)收录期刊
  • 中华预防医学会系列杂志优秀期刊(2019年)

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

发热伴血小板减少综合征感染防控专家共识

胡立芬,  龚磊,  李春辉,  殷俊,  叶英,  郜玉峰,  杨帆,  李军,  瞿婷婷,  程君,  尹华发,  许夕海,  伍婷,  崔宁,  王刚,  黄小平,  徐峰,  徐静,  杨江华,  饶建国,  朱立雨,  刘贞君,  吴家兵,  刘玮,  李家斌

downloadPDF
文章导航 > 中华疾病控制杂志  > 2024 >  28(6): 621-628
胡立芬, 龚磊, 李春辉, 殷俊, 叶英, 郜玉峰, 杨帆, 李军, 瞿婷婷, 程君, 尹华发, 许夕海, 伍婷, 崔宁, 王刚, 黄小平, 徐峰, 徐静, 杨江华, 饶建国, 朱立雨, 刘贞君, 吴家兵, 刘玮, 李家斌. 发热伴血小板减少综合征感染防控专家共识[J]. 中华疾病控制杂志, 2024, 28(6): 621-628. doi: 10.16462/j.cnki.zhjbkz.2024.06.001
引用本文: 胡立芬, 龚磊, 李春辉, 殷俊, 叶英, 郜玉峰, 杨帆, 李军, 瞿婷婷, 程君, 尹华发, 许夕海, 伍婷, 崔宁, 王刚, 黄小平, 徐峰, 徐静, 杨江华, 饶建国, 朱立雨, 刘贞君, 吴家兵, 刘玮, 李家斌. 发热伴血小板减少综合征感染防控专家共识[J]. 中华疾病控制杂志, 2024, 28(6): 621-628. doi: 10.16462/j.cnki.zhjbkz.2024.06.001
shu
HU Lifen, GONG Lei, LI Chunhui, YIN Jun, YE Ying, GAO Yufeng, YANG Fan, LI Jun, QU Tingting, CHENG Jun, YIN Huafa, XU Xihai, WU Ting, CUI Ning, WANG Gang, HUANG Xiaoping, XU Feng, XU Jing, YANG Jianghua, RAO Jianguo, ZHU Liyu, LIU Zhenjun, WU Jiabing, LIU Wei, LI Jiabin. Expert consensus on prevention and control of severe fever with thrombocytopenia syndrome[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(6): 621-628. doi: 10.16462/j.cnki.zhjbkz.2024.06.001
Citation: HU Lifen, GONG Lei, LI Chunhui, YIN Jun, YE Ying, GAO Yufeng, YANG Fan, LI Jun, QU Tingting, CHENG Jun, YIN Huafa, XU Xihai, WU Ting, CUI Ning, WANG Gang, HUANG Xiaoping, XU Feng, XU Jing, YANG Jianghua, RAO Jianguo, ZHU Liyu, LIU Zhenjun, WU Jiabing, LIU Wei, LI Jiabin. Expert consensus on prevention and control of severe fever with thrombocytopenia syndrome[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(6): 621-628. doi: 10.16462/j.cnki.zhjbkz.2024.06.001
shu

发热伴血小板减少综合征感染防控专家共识

doi: 10.16462/j.cnki.zhjbkz.2024.06.001
  • 1.

    安徽医科大学第一附属医院感染病科，合肥 230022

  • 2.

    感染性疾病安徽省重点实验室，合肥 230022

  • 3.

    安徽省疾病预防控制中心，合肥 230022

  • 4.

    中南大学湘雅医院医院感染控制中心，长沙 410008

  • 5.

    安徽医科大学第一附属医院感染管理科，合肥 230022

  • 6.

    复旦大学附属华山医院医院感染管理科，上海 200040

  • 7.

    南京医科大学第一附属医院感染病科，南京 210006

  • 8.

    浙江大学医学院附属第一医院感染管理科，杭州 310003

  • 9.

    安徽省公共卫生临床中心感染科，合肥 230022

  • 10.

    信阳154中心医院感染科，信阳 464000

  • 11.

    山东大学齐鲁医院感染病科，济南 250012

  • 12.

    苏州大学附属第一医院感染病科，苏州 215006

  • 13.

    浙江大学医学院附属第二医院感染病科，杭州 310009

  • 14.

    中国科学技术大学附属第一医院感染病科，合肥 230036

  • 15.

    皖南医学院第一附属医院感染性疾病科，芜湖 241001

  • 16.

    六安市人民医院感染科，六安 237000

  • 17.

    安徽医科大学附属巢湖医院感染疾病科，巢湖 238001

  • 18.

    安庆市立医院感染性疾病科，安庆 246003

  • 19.

    病原微生物生物安全全国重点实验室，军事医学研究院，北京 100850

基金项目: 

国家自然科学基金 82330103

国家自然科学基金 82370016

安徽省重点研究与开发计划项目 2022e07020043

安徽省卫生健康科研重点项目 AHWJ2022a018

安徽省高校自然科学团队项目 2023AH010083

详细信息
    通讯作者:

    刘玮，E-mail: lwbime@163.com

    吴家兵，E-mail: wjb0386@126.com

    李家斌，E-mail: lijiabin@ahmu.edu.cn

  • 中图分类号: R511

Expert consensus on prevention and control of severe fever with thrombocytopenia syndrome

  • 1.

    Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China

  • 2.

    Anhui Province Key Laboratory of Infectious Diseases, Hefei 230022, China

  • 3.

    Anhui Center for Disease Control and Prevention, Hefei 230022, China

  • 4.

    Infection Control Center, Xiangya Hospital of Central South University, Changsha 410008, China

  • 5.

    Hospital Infection-Control Department, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China

  • 6.

    Hospital Infection-Control Department, Huashan Hospital, Fudan University, Shanghai 200040, China

  • 7.

    Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210006, China

  • 8.

    Hospital Infection-Control Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China

  • 9.

    Department of Infectious Diseases, Public Health Clinical Center of Anhui Province, Hefei 230022, China

  • 10.

    Department of Infectious Diseases, The 154th Hospital, Xinyang 464000, China

  • 11.

    Department of Infectious Diseases, Qilu Hospital, Shandong University, Jinan 250012, China

  • 12.

    Department of Infectious Diseases, The First Affiliated Hospital of Suzhou University, Suzhou 215006, China

  • 13.

    Department of Infectious Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China

  • 14.

    Department of Infectious Diseases, The First Affiliated Hospital of University of Science and Technology of China, Hefei 230036, China

  • 15.

    Department of Infectious Diseases, The First Affiliated Hospital of Wannan Medical College, Wuhu 241001, China

  • 16.

    Department of Infectious Diseases, Lu′an People′s Hospital of Anhui Province, Lu′an 237000, China

  • 17.

    Department of Infectious Diseases, Chaohu Hospital of Anhui Medical University, Chaohu 238001, China

  • 18.

    Department of Infectious Diseases, Anqing Municipal Hospital, Anqing 246003, China

  • 19.

    State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing 100850, China

Funds: 

The National Natural Science Foundation of China 82330103

The National Natural Science Foundation of China 82370016

The Key Research and Development Plan Project of Anhui Province 2022e07020043

The Key Health Research Projects of Anhui Province AHWJ2022a018

Anhui Province University Natural Science Team Project 2023AH010083

More Information

    摘要
  • 摘要: 发热伴血小板减少综合征(severe fever with thrombocytopenia syndrome, SFTS)是主要通过蜱虫叮咬使患者感染大别班达病毒(Dabie bandavirus, DBV)的新发传染病。2009年首次在我国中部地区发热伴白细胞及血小板减少患者的血清中分离到该病原体，现在亚洲多个国家流行，重症患者死亡率高。近10年来，国内外关于DBV因人际传播而引发SFTS聚集性的疫情事件时有发生。尤其重症患者容易引起人际传播事件发生，在其抢救和治疗过程中因防护不规范易发生院内感染而导致医护人员感染病毒。因此，迫切需要制定防控DBV人际传播的合理措施，控制疫情蔓延，对临床SFTS重症患者的管理有重要的指导意义和临床价值。为了更好地规范DBV人际传播防控策略，研究邀请了该领域的知名专家进行深入讨论，在SFTS的流行概况、患者的血液和体液接触传播、病毒气溶胶传播、患者的污染物及遗体处理等关键防控措施方面达成了共识。
    Abstract: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by Dabie bandavirus (DBV) transmitted through tick bites. It was initially identified in 2009 among febrile patients with leukopenia and thrombocytopenia in central China. SFTS has been recently reported in other Asia countries, resulting in high mortality among severely ill patients. In the recent 10 years, there have been some reports about human-to-human transmission of DBV, particularly among severely ill patients. However, there are currently no established prevention and control measures for medical staff during the clinical treatment for severely ill SFTS patients against human-to-human transmission. Improper precaution measure can cause nosocomial infection of DBV among medical staff during the clinical process of rescue and treatment. Therefore, it is crucial to develop preventive and control measures against DBV′s human-to-human transmission, which would significantly contribute to the management of severely ill SFTS patients. To better regulate the precaution measures strategies against DBV human-to-human transmission, we have invited renowned experts in this field for extensive discussions, and reached a consensus on prevention and control measures concerning SFTS epidemiological features, contact transmission through patient′s blood and bloody secretions, aerosol transmission, as well as patient′s contaminants handling and corpse disposal.
    • HTML全文

  • 图  1  发热伴血小板减少综合征院内感染防控流程图

    CPR: 心肺复苏术；DBV: 大别班达病毒；RNA: 核糖核酸。

    Figure  1.  Flow chart of prevention and control strategy against nosocomial infection for severe fever with thrombocytopenia syndrome

    CPR: cardiopulmonary resuscitation; DBV: Dabie bandavirus; RNA: ribonucleic acid.

    下载: 全尺寸图片 幻灯片
    • 参考文献(52)
  • [1] Guo CT, Lu QB, Ding SJ, et al. Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis[J]. Epidemiol Infect, 2016, 144(6): 1345-1354. DOI: 10.1017/S0950268815002678.
    [2] Liu W, Lu QB, Cui N, et al. Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in China who had severe fever with thrombocytopenia syndrome[J]. Clin Infect Dis, 2013, 57(9): 1292-1299. DOI: 10.1093/cid/cit530.
    [3] Kim KH, Yi J, Kim G, et al. Severe fever with thrombocytopenia syndrome, South Korea, 2012[J]. Emerg Infect Dis, 2013, 19(11): 1892-1894. DOI: 10.3201/eid1911.130792.
    [4] Takahashi T, Maeda K, Suzuki T, et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan[J]. J Infect Dis, 2014, 209(6): 816-827. DOI: 10.1093/infdis/jit603.
    [5] Kobayashi Y, Kato H, Yamagishi T, et al. Severe fever with thrombocytopenia syndrome, Japan, 2013-2017[J]. Emerg Infect Dis, 2020, 26(4): 692-699. DOI: 10.3201/eid2604.191011.
    [6] Li JC, Zhao J, Li H, et al. Epidemiology, clinical characteristics, and treatment of severe fever with thrombocytopenia syndrome[J]. Infect Med, 2022, 1(1): 40-49. DOI: 10.1016/j.imj.2021.10.001.
    [7] Mehand MS, Millett P, Al-Shorbaji F, et al. World health organization methodology to prioritize emerging infectious diseases in need of research and development[J]. Emerg Infect Dis, 2018, 24(9): e171427. DOI: 10.3201/eid2409.171427.
    [8] Bao CJ, Guo XL, Qi X, et al. A family cluster of infections by a newly recognized bunyavirus in Eastern China, 2007: further evidence of person-to-person transmission[J]. Clin Infect Dis, 2011, 53(12): 1208-1214. DOI: 10.1093/cid/cir732.
    [9] Gai ZT, Liang MF, Zhang Y, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus through blood contact[J]. Clin Infect Dis, 2012, 54(2): 249-252. DOI: 10.1093/cid/cir776.
    [10] Liu Y, Li Q, Hu WF, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome virus[J]. Vector Borne Zoonotic Dis, 2012, 12(2): 156-160. DOI: 10.1089/vbz.2011.0758.
    [11] Tang XY, Wu WL, Wang HF, et al. Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood[J]. J Infect Dis, 2013, 207(5): 736-739. DOI: 10.1093/infdis/jis748.
    [12] Chen HB, Hu K, Zou JJ, et al. A cluster of cases of human-to-human transmission caused by severe fever with thrombocytopenia syndrome bunyavirus[J]. Int J Infect Dis, 2013, 17(3): e206-e208. DOI: 10.1016/j.ijid.2012.11.006.
    [13] Wang YL, Deng BC, Zhang J, et al. Person-to-person asymptomatic infection of severe fever with thrombocytopenia syndrome virus through blood contact[J]. Intern Med, 2014, 53(8): 903-906. DOI: 10.2169/internalmedicine.53.1164.
    [14] Jiang XL, Zhang S, Jiang M, et al. A cluster of person-to-person transmission cases caused by SFTS virus in Penglai, China[J]. Clin Microbiol Infect, 2015, 21(3): 274-279. DOI: 10.1016/j.cmi.2014.10.006.
    [15] Gong Z, Gu S, Zhang Y, et al. Probable aerosol transmission of severe fever with thrombocytopenia syndrome virus in southeastern China[J]. Clin Microbiol Infect, 2015, 21(12): 1115-1120. DOI: 10.1016/j.cmi.2015.07.024.
    [16] Kim WY, Choi W, Park SW, et al. Nosocomial transmission of severe fever with thrombocytopenia syndrome in Korea[J]. Clin Infect Dis, 2015, 60(11): 1681-1683. DOI: 10.1093/cid/civ128.
    [17] Yoo JR, Heo ST, Park D, et al. Family cluster analysis of severe fever with thrombocytopenia syndrome virus infection in Korea[J]. Am J Trop Med Hyg, 2016, 95(6): 1351-1357. DOI: 10.4269/ajtmh.16-0527.
    [18] Huang DY, Jiang YP, Liu XP, et al. A cluster of symptomatic and asymptomatic infections of severe fever with thrombocytopenia syndrome caused by person-to-person transmission[J]. Am J Trop Med Hyg, 2017, 97(2): 396-402. DOI: 10.4269/ajtmh.17-0059.
    [19] Gong L, Song DD, Wu JB, et al. Human-to-human transmissions of severe fever with thrombocytopenia syndrome virus in Anhui Province, 2010-2017[J]. Clin Microbiol Infect, 2018, 24(8): 920-922. DOI: 10.1016/j.cmi.2018.03.014.
    [20] Moon J, Lee H, Jeon JH, et al. Aerosol transmission of severe fever with thrombocytopenia syndrome virus during resuscitation[J]. Infect Control Hosp Epidemiol, 2019, 40(2): 238-241. DOI: 10.1017/ice.2018.330.
    [21] Jung IY, Choi W, Kim J, et al. Nosocomial person-to-person transmission of severe fever with thrombocytopenia syndrome[J]. Clin Microbiol Infect, 2019, 25(5): 633.e1-633633.e4. DOI: 10.1016/j.cmi.2019.01.006.
    [22] Tao MY, Liu Y, Ling F, et al. Characteristics of three person-to-person transmission clusters of severe fever with thrombocytopenia syndrome in southeastern China[J]. Am J Trop Med Hyg, 2021, 105(3): 794-800. DOI: 10.4269/ajtmh.21-0366.
    [23] Ye C, Qi R. Risk factors for person-to-person transmission of severe fever with thrombocytopenia syndrome[J]. Infect Control Hosp Epidemiol, 2021, 42(5): 582-585. DOI: 10.1017/ice.2020.1258.
    [24] Fang XY, Hu JL, Peng ZH, et al. Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome bunyavirus human-to-human transmission[J]. PLoS Negl Trop Dis, 2021, 15(4): e0009037. DOI: 10.1371/journal.pntd.0009037.
    [25] Wu YX, Yang X, Leng Y, et al. Human-to-human transmission of severe fever with thrombocytopenia syndrome virus through potential ocular exposure to infectious blood[J]. Int J Infect Dis, 2022, 123: 80-83. DOI: 10.1016/j.ijid.2022.08.008.
    [26] Hu L, Li J, Zhang H, et al. Predisposing factors for person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus[J]. J Hosp Infect, 2022, 123: 174-178. DOI: 10.1016/j.jhin.2021.10.023.
    [27] Bae S, Chang HH, Kim SW, et al. Nosocomial outbreak of severe fever with thrombocytopenia syndrome among healthcare workers in a single hospital in Daegu, Korea[J]. Int J Infect Dis, 2022, 119: 95-101. DOI: 10.1016/j.ijid.2022.03.048.
    [28] 杨鑫, 武永祥, 冷昱, 等. 两起发热伴血小板减少综合征聚集性疫情流行病学及病原学分析[J]. 遗传, 2023, 45(11): 1062-1073. DOI: 10.16288/j.yczz.23-176.

    Yang X, Wu YX, Leng Y, et al. Epidemiololgical and etiological analysis of two clusters of severe fever with thrombocytopenia syndrome[J]. Hereditas, 2023, 45(11): 1062-1073. DOI: 10.16288/j.yczz.23-176.
    [29] 张爱平, 梁曼曼, 王子健, 等. 对比分析蜱传人和人传人致发热伴血小板减少综合征的临床特征及预后[J]. 新发传染病电子杂志, 2022, 7(1): 26-29. DOI: 10.19871/j.cnki.xfcrbzz.2022.01.006.

    Zhang AP, Liang MM, Wang ZJ, et al. Comparison of clinical features and prognosis of severe fever with thrombocytopenia syndrome transmitted from tick-to-person versus person-to-person[J]. Electronic Journal of Emerging Infectious Diseases, 2022, 7(1): 26-29. DOI: 10.19871/j.cnki.xfcrbzz.2022.01.006.
    [30] 李懿, 王笑阳, 李亚飞, 等. 2022年河南省两起发热伴血小板减少综合征聚集性疫情流行病学及病原学调查[J]. 中华预防医学杂志, 2023, 57(10): 1719-1724. DOI: 10.3760/cma.j.cn112150-20221130-01162.

    Li Y, Wang XY, Li YF, et al. The epidemiology and pathogeny investigation of two clusters of severe fever with thrombocytopenia syndrome disease outbreaking in Henan Province, 2022[J]. Chin J Prev Med, 2023, 57(10): 1719-1724. DOI: 10.3760/cma.j.cn112150-20221130-01162.
    [31] 张全福, 李建东, 姜晓林, 等. 发热伴血小板减少综合征病毒热稳定性和灭活条件初步研究[J]. 中华实验和临床病毒学杂志, 2014, 28(3): 206-208. DOI: 10.3760/cma.j.issn.1003-9279.2014.03.016.

    Zhang QF, Li JD, Jiang XL, et al. A primary study of the thermal stability and inactivation of severe fever with thrombocytopenia syndrome virus[J]. Chin J Exp Clin Virol, 2014, 28(3): 206-208. DOI: 10.3760/cma.j.issn.1003-9279.2014.03.016.
    [32] 杨晓艺, 杜珊珊, 黄晓霞, 等. 发热伴血小板减少综合征病毒在不同环境条件下的稳定性研究[J]. 病毒学报, 2023, 39(6): 1521-1527. DOI: 10.13242/j.cnki.bingduxuebao.004391.

    Yang XY, Du SS, Huang XX, et al. Comparative study on the environmental stability of severe fever with thrombocytopenia syndrome virus[J]. Chinese Journal of Virology, 2023, 39(6): 1521-1527. DOI: 10.13242/j.cnki.bingduxuebao.004391.
    [33] 陈秋兰, 朱曼桐, 陈宁, 等. 2011-2021年全国发热伴血小板减少综合征流行特征分析[J]. 中华流行病学杂志, 2022, 43(6): 852-859. DOI: 10.3760/cma.j.cn112338-20220325-00228.

    Chen QL, Zhu MT, Chen N, et al. Epidemiological characteristics of severe fever with thtrombocytopenia syndrome in China, 2011-2021[J]. Chin J Epidemiol, 2022, 43(6): 852-859. DOI: 10.3760/cma.j.cn112338-20220325-00228.
    [34] Tran XC, Yun Y, An L, et al. Endemic severe fever with thrombocytopenia syndrome, Vietnam[J]. Emerg Infect Dis, 2019, 25(5): 1029-1031. DOI: 10.3201/eid2505.181463.
    [35] Win AM, Nguyen YTH, Kim Y, et al. Genotypic heterogeneity of Orientia tsutsugamushi in scrub typhus patients and thrombocytopenia syndrome co-infection, Myanmar[J]. Emerg Infect Dis, 2020, 26(8): 1878-1881. DOI: 10.3201/eid2608.200135.
    [36] Zohaib A, Zhang JY, Saqib M, et al. Serologic evidence of severe fever with thrombocytopenia syndrome virus and related viruses in Pakistan[J]. Emerg Infect Dis, 2020, 26(7): 1513-1516. DOI: 10.3201/eid2607.190611.
    [37] Lin TL, Ou SC, Maeda K, et al. The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan[J]. Emerg Microbes Infect, 2020, 9(1): 148-151. DOI: 10.1080/22221751.2019.1710436.
    [38] Casel MA, Park SJ, Choi YK. Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy[J]. Exp Mol Med, 2021, 53(5): 713-722. DOI: 10.1038/s12276-021-00610-1.
    [39] Zhao L, Li J, Cui XM, et al. Distribution of Haemaphysalis longicornis and associated pathogens: analysis of pooled data from a China field survey and global published data[J]. Lancet Planet Health, 2020, 4(8): e320-e329. DOI: 10.1016/S2542-5196(20)30145-5.
    [40] Zhang X, Zhao CY, Cheng CY, et al. Rapid spread of severe fever with thrombocytopenia syndrome virus by parthenogenetic Asian longhorned ticks[J]. Emerg Infect Dis, 2022, 28(2): 363-372. DOI: 10.3201/eid2802.211532.
    [41] Wang JN, Li TQ, Liu QM, et al. Vectors, hosts, and the possible risk factors associated with severe fever with thrombocytopenia syndrome[J]. J Can Des Mal Infect De La Microbiol Med, 2021, 2021: 8518189. DOI: 10.1155/2021/8518189.
    [42] Park ES, Shimojima M, Nagata N, et al. Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats[J]. Sci Rep, 2019, 9(1): 11990. DOI: 10.1038/s41598-019-48317-8.
    [43] Yamanaka A, Kirino Y, Fujimoto S, et al. Direct transmission of severe fever with thrombocytopenia syndrome virus from domestic cat to veterinary personnel[J]. Emerg Infect Dis, 2020, 26(12): 2994-2998. DOI: 10.3201/eid2612.191513.
    [44] Kida K, Matsuoka Y, Shimoda T, et al. A case of cat-to-human transmission of severe fever with thrombocytopenia syndrome virus[J]. Jpn J Infect Dis, 2019, 72(5): 356-358. DOI: 10.7883/yoken.JJID.2018.526.
    [45] Tsuru M, Suzuki T, Murakami T, et al. Pathological characteristics of a patient with severe fever with thrombocytopenia syndrome (SFTS) infected with SFTS virus through a sick cat's bite[J]. Viruses, 2021, 13(2): 204. DOI: 10.3390/v13020204.
    [46] Mekata H, Kawaguchi T, Iwao K, et al. Possible transmission of severe fever with the thrombocytopenia syndrome virus to an individual who buried an infected cat[J]. Jpn J Infect Dis, 2023, 76(3): 211-214. DOI: 10.7883/yoken.JJID.2022.425.
    [47] Kaneko C, Mekata H, Umeki K, et al. Seroprevalence of severe fever with thrombocytopenia syndrome virus in medium-sized wild mammals in Miyazaki, Japan[J]. Ticks Tick Borne Dis, 2023, 14(2): 102115. DOI: 10.1016/j.ttbdis.2022.102115.
    [48] 李兵, 刘元东, 周光智, 等. 发热伴血小板减少综合征的流行病学特征及防治措施[J]. 解放军预防医学杂志, 2017, 35(12): 1623-1626. DOI: 10.13704/j.cnki.jyyx.2017.12.043.

    Li B, Liu YD, Zhou GZ, et al. Epidemiological characteristics and preventive measures of fever with thrombocytopenia syndrome[J]. J Prev Med Chin Peopl Liber Army, 2017, 35(12): 1623-1626. DOI: 10.13704/j.cnki.jyyx.2017.12.043.
    [49] Dualis H, Zefong AC, Joo LK, et al. Factors and outcomes in severe fever with thrombocytopenia syndrome (SFTS): a systematic review[J]. Ann Med Surg, 2021, 67: 102501. DOI: 10.1016/j.amsu.2021.102501.
    [50] Li H, Lu QB, Xing B, et al. Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study[J]. Lancet Infect Dis, 2018, 18(10): 1127-1137. DOI: 10.1016/S1473-3099(18)30293-7.
    [51] Ryu BH, Kim JY, Kim T, et al. Extensive severe fever with thrombocytopenia syndrome virus contamination in surrounding environment in patient rooms[J]. Clin Microbiol Infect, 2018, 24(8): 911.e1-911911.e4. DOI: 10.1016/j.cmi.2018.01.005.
    [52] Wei XM, Li SH, Lu Y, et al. Severe fever with thrombocytopenia syndrome virus aerosol infection in C57/BL6 mice[J]. Virology, 2023, 581: 58-62. DOI: 10.1016/j.virol.2023.03.001.
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
图(1)
计量
  • 文章访问数:  383
  • HTML全文浏览量:  67
  • PDF下载量:  107
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-03-20
  • 修回日期:  2024-05-13
  • 网络出版日期:  2024-07-13
  • 刊出日期:  2024-06-10

目录

    /

    返回文章
    返回

    版权所有 © 《中华疾病控制杂志》编辑部 皖ICP备05003562号

    本系统由 北京仁和汇智信息技术有限公司 开发